Medtronic Management Discusses Q1 2013 Results - Earnings Call Transcript

Medtronic (MDT)

Q1 2013 Earnings Call

August 21, 2012 8:00 am ET


Jeff Warren

Omar S. Ishrak - Chairman and Chief Executive Officer

Gary L. Ellis - Chief Financial Officer, Principal Accounting Officer and Senior Vice President

Michael J. Coyle - Executive Vice President and Group President of Cardiac & Vascular Group

Christopher J. O'Connell - Executive Vice President and Group President of Restorative Therapies Group


Matthew J. Dodds - Citigroup Inc, Research Division

Michael N. Weinstein - JP Morgan Chase & Co, Research Division

David R. Lewis - Morgan Stanley, Research Division

Kristen M. Stewart - Deutsche Bank AG, Research Division

Rajeev Jashnani - UBS Investment Bank, Research Division

Robert A. Hopkins - BofA Merrill Lynch, Research Division

Topher Orr - Goldman Sachs Group Inc., Research Division

Bruce M. Nudell - Crédit Suisse AG, Research Division

Joshua T. Jennings - Cowen and Company, LLC, Research Division

Derrick Sung - Sanford C. Bernstein & Co., LLC., Research Division

Joanne K. Wuensch - BMO Capital Markets U.S.



Good morning. My name is Christie, and I will be your conference operator today. At this time, I would like to welcome everyone to the Medtronic's First Quarter Earnings Release Conference Call. [Operator Instructions] Thank you. It is now my pleasure to hand the program over to Mr. Jeff Warren. Please go ahead.

Jeff Warren

Thank you, Christie. Good morning, and welcome to Medtronic's First Quarter Conference Call and Webcast. During the next hour, Omar Ishrak, Medtronic Chairman and Chief Executive Officer; and Gary Ellis, Medtronic Chief Financial Officer, will provide comments on the results of our fiscal year 2013 first quarter, which ended July 27, 2012. After our prepared remarks, we will be happy to take your questions.

If you liked this article you might like

Medtronic Looks Vulnerable to a Bigger Decline

FDA Approves Abbott Heart Device, Stock Rises

Measure the Meaning of This Rally: Cramer's 'Mad Money' Recap (Tues 8/22/17)

The 10 Stocks America's Biggest Hedge Funds Are Dumping Like Crazy

Cramer: This Rally Isn't Without Meaning